Showing results (601-610 of 618) with videos related to

Sort By:
Pageof 62
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|November 13, 2017
[A reporting tool for practice guidelines in health care: the RIGHT statement]Yaolong Chen, Kehu Yang, Ana Marušić, et al.
Nature Communications|May 17, 2022
Mutational landscape of normal epithelial cells in Lynch Syndrome patientsBernard C H Lee, Philip S Robinson, Tim H H Coorens, et al.
Prehospital Emergency Care|August 26, 2014
Rationale, Methodology, and Implementation of a Dispatcher-assisted Cardiopulmonary Resuscitation Trial in the Asia-Pacific (Pan-Asian Resuscitation Outcomes Study Phase 2)Marcus Eng Hock Ong, Sang Do Shin, Hideharu Tanaka, et al.
Gut|March 29, 2020
Organoid cultures of early-onset colorectal cancers reveal distinct and rare genetic profilesHelen H N Yan, Hoi Cheong Siu, Siu Lun Ho, et al.
The Journal of Experimental Medicine|October 19, 2011
DOCK8 deficiency impairs CD8 T cell survival and function in humans and miceKatrina L Randall, Stephanie S-Y Chan, Cindy S Ma, et al.
The Pharmacogenomics Journal|January 18, 2012
Novel mRNA isoforms and mutations of uridine monophosphate synthetase and 5-fluorouracil resistance in colorectal cancerM Griffith, J C Mwenifumbo, P Y Cheung, et al.
The Lancet Regional Health. Western Pacific|August 7, 2023
The impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumoursAya El Helali, Tai-Chung Lam, Elaine Yee-Ling Ko, et al.
The Lancet. Oncology|June 14, 2012
Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysisDaniel Picard, Suzanne Miller, Cynthia E Hawkins, et al.
Cell Stem Cell|October 23, 2018
A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic ScreeningHelen H N Yan, Hoi Cheong Siu, Simon Law, et al.
Cancer Medicine|March 19, 2020
Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantationHarinder Gill, Rita Yim, Herbert H Pang, et al.
Pageof 62